PRKN and Parkinson disease: •These data may be used to perform multilevel comparative transcriptomic analysis of NPs and neurons in healthy donors and PD patients with mutations in various PARK2 exons, as well as to evaluate transcriptional features that healthy or PD NPs acquire during differentiation into mature neurons.